leisure time -WSS

leisure time

author：entertainment 2025-09-02 22:24:34 - browse：2

Ethylene Oxide Sterilizer machine. -- health tech coverage from STAT — Ethylene oxide, a chemical used to sterilize half of all medical devices in the U.S., can also cause cancer. 3M via AP

The chemical used to sterilize half of all medical devices in the United States is also known to cause cancer. After years of deliberating on alternatives, the Food and Drug Administration this month deemed a safer gas, vaporized hydrogen peroxide, a legitimate way to decontaminate devices.

It’s a small step in pushing the medical device industry away from the carcinogenic chemical, called ethylene oxide. The move comes as the Environmental Protection Agency prepares to finalize restrictions on ethylene oxide in March. Medical device manufacturers will have 18 months to comply.

Environmental activists organizing against the sterilizing facilities in their communities commend the EPA for curtailing the chemical. But they also want the FDA to more adamantly push device makers toward alternatives, which the FDA’s endorsement does not do.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How Vertex's cystic fibrosis drug is changing patients' lives

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

CDC advisers recommend seasonal use of Pfizer RSV shot

Thermo Fisher plant for manufacturing gene therapies to expand

How Vertex's cystic fibrosis drug is changing patients' lives

First Opinion Podcast: Long Covid needs a new approach

Thermo Fisher plant for manufacturing gene therapies to expand

Wikipedia

leisure time

knowledge

Psychedelics group wrestles with new pharma identity

Changes to biosimilar regulatory framework must prioritize patients

Medicare details structure of new drug price negotiation program

CommonSpirit Health keeps growing, even as it loses money

Sports medicine is finally prioritizing gender equality

Changes to biosimilar regulatory framework must prioritize patients

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The EU Joint Clinical Assessment needs to live up to its promise

Psychedelics group wrestles with new pharma identity

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

explore

Readout LOUD podcast: possible new ALS drug, artificial wombs

STAT Summit: GSK CEO on pharma giant's new direction

FDA panel to weigh approval of NurOwn, controversial ALS drug

Senate HELP committee spars over health care workforce policies

Biotech stock slump in 2023: awaiting the turnaround

Solve the antibiotic resistance crisis with preventive drugs

Wikipedia

knowledge

focus

explore